Mukka Proteins Limited

🔴 Bear CaseWhat could go wrong?

1. The debt load needs earnings to hold up
   Debt is 6.1x EBITDA. At that level a downturn in earnings turns a manageable balance sheet into a refinancing problem, and lenders get paid before shareholders.
2. Sales are being booked faster than collected
   Receivables are up 61% against revenue up 21%. If customers keep taking longer to pay, reported profit will not turn into cash — and write-offs follow if some never do.
3. Growth barely outpaces inflation
   Revenue compounding at 6.7% a year is close to the rate prices rise, so the business is gaining little ground in real terms. That leaves the share price dependent on a re-rating rather than on earnings growth.
4. Returns on shareholder capital are falling
   ROE has dropped from 29.8% to 10.4%. Each rupee of equity earns less than it did, so profit growth increasingly depends on raising more capital rather than on the existing base working harder.
5. Size brings its own risk
   Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.